195 related articles for article (PubMed ID: 37931072)
21. Microfluidic Post-Insertion Method for the Efficient Preparation of PEGylated Liposomes Using High Functionality and Quality Lipids.
Sugimoto Y; Suga T; Kato N; Umino M; Yamayoshi A; Mukai H; Kawakami S
Int J Nanomedicine; 2022; 17():6675-6686. PubMed ID: 36597433
[TBL] [Abstract][Full Text] [Related]
22. Microfluidic production of protein loaded chimeric stealth liposomes.
Hussain MT; Tiboni M; Perrie Y; Casettari L
Int J Pharm; 2020 Nov; 590():119955. PubMed ID: 33035609
[TBL] [Abstract][Full Text] [Related]
23. The Manufacturing and Characterisation of Eugenol-Enclosed Liposomes Produced by Microfluidic Method.
Ghodke J; Ekonomou SI; Weaver E; Lamprou D; Doran O; Stratakos AC
Foods; 2023 Aug; 12(15):. PubMed ID: 37569209
[TBL] [Abstract][Full Text] [Related]
24. [Preparation of cell penetrating peptide TAT and cleavable PEGco-modified liposomes loaded with paclitaxel and its in vitro apoptosis assay].
Fu H; Hu GL; He Q
Yao Xue Xue Bao; 2014 Jul; 49(7):1054-61. PubMed ID: 25233640
[TBL] [Abstract][Full Text] [Related]
25. [Optimization of Formulation and Process of Paclitaxel PEGylated Liposomes by Box-Behnken Response Surface Methodology].
Shi YJ; Zhang XF; Guo QT
Zhong Yao Cai; 2015 Dec; 38(12):2606-10. PubMed ID: 27352544
[TBL] [Abstract][Full Text] [Related]
26. Manufacturing drug co-loaded liposomal formulations targeting breast cancer: Influence of preparative method on liposomes characteristics and in vitro toxicity.
Gkionis L; Campbell RA; Aojula H; Harris LK; Tirella A
Int J Pharm; 2020 Nov; 590():119926. PubMed ID: 33010397
[TBL] [Abstract][Full Text] [Related]
27. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
28. Rapid and scale-independent microfluidic manufacture of liposomes entrapping protein incorporating in-line purification and at-line size monitoring.
Forbes N; Hussain MT; Briuglia ML; Edwards DP; Horst JHT; Szita N; Perrie Y
Int J Pharm; 2019 Feb; 556():68-81. PubMed ID: 30503269
[TBL] [Abstract][Full Text] [Related]
29. Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic.
Olerile LD; Liu Y; Zhang B; Wang T; Mu S; Zhang J; Selotlegeng L; Zhang N
Colloids Surf B Biointerfaces; 2017 Feb; 150():121-130. PubMed ID: 27907859
[TBL] [Abstract][Full Text] [Related]
30. Sirolimus-loaded stealth colloidal systems attenuate neointimal hyperplasia after balloon injury: a comparison of phospholipid micelles and liposomes.
Haeri A; Sadeghian S; Rabbani S; Anvari MS; Lavasanifar A; Amini M; Dadashzadeh S
Int J Pharm; 2013 Oct; 455(1-2):320-30. PubMed ID: 23867987
[TBL] [Abstract][Full Text] [Related]
31. Liposome formulation of paclitaxel with enhanced solubility and stability.
Yang T; Cui FD; Choi MK; Lin H; Chung SJ; Shim CK; Kim DD
Drug Deliv; 2007 Jul; 14(5):301-8. PubMed ID: 17613018
[TBL] [Abstract][Full Text] [Related]
32. Docetaxel-loaded liposomes: The effect of lipid composition and purification on drug encapsulation and in vitro toxicity.
Pereira S; Egbu R; Jannati G; Al-Jamal WT
Int J Pharm; 2016 Nov; 514(1):150-159. PubMed ID: 27863659
[TBL] [Abstract][Full Text] [Related]
33. Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo.
Cai L; Wang X; Wang W; Qiu N; Wen J; Duan X; Li X; Chen X; Yang L; Qian Z; Wei Y; Chen L
Int J Nanomedicine; 2012; 7():4499-510. PubMed ID: 22923988
[TBL] [Abstract][Full Text] [Related]
34. Novel microfluidic swirl mixers for scalable formulation of curcumin loaded liposomes for cancer therapy.
Xu R; Tomeh MA; Ye S; Zhang P; Lv S; You R; Wang N; Zhao X
Int J Pharm; 2022 Jun; 622():121857. PubMed ID: 35623489
[TBL] [Abstract][Full Text] [Related]
35. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
Nasri N; Saharkhiz S; Dini G; Yousefnia S
Int J Pharm; 2023 Dec; 648():123606. PubMed ID: 37972671
[TBL] [Abstract][Full Text] [Related]
36. Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery.
Gao D; Tang S; Tong Q
Int J Nanomedicine; 2012; 7():3517-26. PubMed ID: 22848175
[TBL] [Abstract][Full Text] [Related]
37. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes.
Crosasso P; Ceruti M; Brusa P; Arpicco S; Dosio F; Cattel L
J Control Release; 2000 Jan; 63(1-2):19-30. PubMed ID: 10640577
[TBL] [Abstract][Full Text] [Related]
38. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
[TBL] [Abstract][Full Text] [Related]
39. Liposomal encapsulation of amoxicillin via microfluidics with subsequent investigation of the significance of PEGylated therapeutics.
Weaver E; Macartney RA; Irwin R; Uddin S; Hooker A; Burke GA; Wylie MP; Lamprou DA
Int J Pharm; 2024 Jan; 650():123710. PubMed ID: 38097147
[TBL] [Abstract][Full Text] [Related]
40. Preparation, characterization, pharmacokinetics and anticancer effects of PEGylated β-elemene liposomes.
Zhai B; Wu Q; Wang W; Zhang M; Han X; Li Q; Chen P; Chen X; Huang X; Li G; Zhang Q; Zhang R; Xiang Y; Liu S; Duan T; Lou J; Xie T; Sui X
Cancer Biol Med; 2020 Feb; 17(1):60-75. PubMed ID: 32296587
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
